Tristan Clark

Council Member UK

Professor and Honorary Consultant in Infectious diseases School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton and University Hospital Southampton NHS Foundation Trust, UK

Professor Clark is a Professor and Honorary Consultant in Infectious Diseases at the University of Southampton and University Hospitals Southampton NHS Trust. Clark trained in Southampton, London, Leicester, Australia and Africa and was awarded his chair by the University of Southampton in 2022. His research involves clinical trials of vaccines, antivirals and rapid diagnostic tests for influenza and other infections. Clark has been an NIHR fellowship holder and have been awarded competitive grant funding from NIHR, Research Councils, EU, and have strong links with the diagnostics industry. Clark has published the results of his trials in The New England Journal of Medicine and Lancet series journals and have over 100 publications in peer reviewed scientific journals. During the COVID-19 pandemic he acted as a scientific advisor to the UK Department of Health and Social Care on rapid diagnostic testing and led on the deployment of rapid testing to UK emergency departments. Clark is a member of the British Infection Association Scientific Affairs Committee and an Editor for the BIA Journal of Infection (impact factor 14). Clark’s overarching professional goal is to promote scientific excellence and his research aims to improve patient outcomes and experience though the evidence-based use of diagnostics, antivirals and vaccines.

Professor Clark has been a member of ISRV since 2016 and has supported the society though regular attendance at international meetings and preferential submission of high-quality scientific data as abstracts. The quality of Clark’s research has been recognised by ISRV through awards for best abstract at the Options X meeting, Singapore, 2019.

Professor Clark said, “I am applying to become a member of the ISRV council as I believe I can work with the society and help it to achieve its strategic goals. This will include strengthening its links with UK infection societies and their scientific meetings and journals, promotion and championing of applied clinical research (including diagnostics research) at ISRV meetings, promoting ISRV activities to UK early career researchers, and by strengthening its links with industry including diagnostics companies.”